.jpg)
Serum Institute of India's (SII) CEO Adar Poonawalla on Wednesday said that his company is confident of receiving approval from the European Medicines Agency (EMA) for the COVID-19 vaccine Covishield in a month. "The EMA is absolutely correct in asking us to apply, which we have through AstraZeneca," he said. "And that process has to take its time," he added.
Serum Institute of India's (SII) CEO Adar Poonawalla on Wednesday said that his company is confident of receiving approval from the European Medicines Agency (EMA) for the COVID-19 vaccine Covishield in a month. "The EMA is absolutely correct in asking us to apply, which we have through AstraZeneca," he said. "And that process has to take its time," he added.
